Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial - Folprecht, G; Gruenberger, T; Bechstein, WO (Lancet Oncol, 2010)
et al.